Why We Need an Alzheimer’s Moonshot in 2022
Genuv calls for an urgent, all-hands-on-deck drug development effort to ameliorate the fast-worsening health crisis that is Alzheimer’s disease
By Sungho Han, PhD, and Allan I. Levey, MD, PhD
When science changes, it often takes a long time for nonscientists to catch up.
The prevailing belief for many decades was that humans are born with a fixed number of brain cells, or neurons, and those hardy cells needed to last a lifetime. But many would unfortunately be lost prematurely due to the use of alcohol and participation in violent sports.
To view original article, please click here.